
Precision nutrition has substantially reshaped nutritional science by demonstrating that individuals can respond differently to identical dietary exposures. Advances in genomics, metabolomics, proteomics, microbiome research, wearable technologies, digital health, and artificial intelligence have improved our ability to characterize biological heterogeneity and predict individual responses to diet. However, demonstrating such variability does not necessarily result in nutritional strategies that provide clinically meaningful benefits beyond established evidence-based care. A critical distinction should therefore be made between precision nutrition as a discovery science, which has convincingly established interindividual heterogeneity in dietary responses, and precision nutrition as an intervention science, which must demonstrate meaningful incremental value over dietary approaches already supported by clinical evidence. Despite increasingly sophisticated technologies and predictive models, evidence of consistent improvements in long-term health outcomes, cost-effectiveness, scalability, and equity remains limited. In this Perspective, we argue that precision nutrition has reached a critical crossroads. We distinguish prediction of individual responses, which is only one route to precision nutrition, from treatment-effect heterogeneity, treatment selection and clinical utility. We then propose contextual precision nutrition as a translational framework that integrates biological responsiveness with the behavioral, psychological, social, cultural, economic, and environmental determinants of dietary behavior. Rather than claiming novelty for these components, the framework integrates them into a decision logic that asks whether biological information improves the selection of a dietary strategy beyond routine information and established care, and how that strategy can be delivered and sustained. It complements population-based dietary recommendations by refining their implementation and maximizing adherence and real-world effectiveness. Ultimately, the success of precision nutrition will be determined not by the sophistication of its predictions but by its ability to translate biological knowledge into interventions that are clinically effective, scalable, equitable, and sustainable, thereby improving both individual and population health.
The expanding availability of continuous glucose monitors (CGMs) has generated growing interest in their application beyond diabetes management, particularly in healthy individuals seeking to optimize metabolic health through personalized nutrition. In May 2025, the Institute for the Advancement of Food and Nutrition Sciences (IAFNS) convened a multidisciplinary expert workshop to examine the scientific, methodological, and clinical considerations surrounding continuous glucose monitor (CGM) application in healthy populations. Discussions addressed normal glycemic physiology, determinants of postprandial glycemic responses (PPGRs), CGM use and functional health outcomes, research applications, and implications for clinical practice. The purpose of this initiative was to develop a perspective paper that synthesizes current evidence and provides guidance on these key considerations to inform responsible research, clinical interpretation, and future policy related to CGM use in populations who do not have diabetes mellitus. Evidence discussed during the workshop underscored substantial inter- and intra-individual variability in PPGRs driven by complex interactions among dietary composition, lifestyle behaviors, and physiological characteristics. CGMs offer the ability to capture these dynamics under real-world conditions and may help identify meaningful individual differences, particularly as PPGRs are increasingly recognized as sensitive markers of early disturbances in glucose regulation. However, important limitations constrain interpretation in healthy populations, including analytical variability, limited precision for single-meal or acute assessments, lack of standardized research protocols and consensus guidance, and insufficient evidence linking CGM-derived metrics to long-term clinical outcomes. High-quality randomized controlled trials, standardized protocols, consensus guidance and integrated metabolic frameworks are needed to determine the clinical relevance of CGM use in healthy populations. Until such evidence is established, CGM use outside of diabetes care should be approached cautiously and ideally within structured research or in clinical contexts that provide appropriate education and professional oversight. STATEMENT OF SIGNIFICANCE: This perspective addresses an important and timely gap in nutrition and health research by evaluating the scientific considerations, methodological limitations, and clinical implications of CGM use in individuals living without diabetes. This paper provides important insights and considerations for the potential integration of CGMs into personalized nutrition research and practice.